Masatora Narita

发表

Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease‐Activated Receptor Pathway

H. Tomita, K. Okumura, T. Osanai, 2019, Journal of the American Heart Association.

Relationship Between Serum Eicosapentaenoic Acid Levels and J-Waves in a General Population in Japan.

H. Tomita, K. Okumura, S. Nakaji, 2018, International heart journal.

Relationship Between Serum Eicosapentaenoic Acid Levels and J-Waves in a General Population in Japan Analysis of the Iwaki Health Promotion Project

H. Tomita, K. Okumura, S. Nakaji, 2018 .

Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice

H. Tomita, K. Okumura, T. Osanai, 2021, Hypertension Research.

Novel Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy in the Japanese General Population.

H. Tomita, K. Sawada, Itoyo Tokuda, 2019, International heart journal.

Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin.

H. Tomita, K. Okumura, T. Osanai, 2018, International heart journal.

Blockade of PAR‐1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin‐Overexpressing Hypertensive Mice

H. Tomita, K. Itoh, Yota Tatara, 2020, Journal of the American Heart Association.

The F(ab′)2 fragment of an Aβ-specific monoclonal antibody reduces Aβ deposits in the brain

K. Matsui, K. Hamajima, K. Xin, 2005, Neurobiology of Disease.

The F(ab)'2 fragment of an Abeta-specific monoclonal antibody reduces Abeta deposits in the brain.

K. Matsui, K. Hamajima, K. Xin, 2005, Neurobiology of disease.